Abattis: Fully Integrated Medical Marijuana Company

CEO & President of Abattis Bioceuticals Corp., Robert Abenante speaks on the medical marijuana company’s many facets including; a vape line, extraction and laboratory services.

“Abattis Bioceuticals is a fully integrated medical marijuana company. We do everything from laboratory services, testing analysis, extraction, growing, we have an LP license on a way, to vape sales. We have our own branded vape line and we’re very quickly going to be launching a whole line of products which will be cannabis infused. We are one of the first medical marijuana companies on the CSE. We’re doing some pretty cutting-edge research with the University of British Colombia right now we actually got a Mitacs grant as well to perform research on nano multiplication. We’re now to launch a larger lab in Ontario, we’re doing it in concession with a company called XLABS Therapeutics and that’s going be a 10,000 square foot lot to start with room for a significant expansion. So, we’ve purchased a late stage LP, as soon as that comes online also have a license to sell so we’ll be able to not only infuse our products but sell them on the retail market. And very recently we also purchased Vape Line. We’ve since rebranded the whole line, Abattis that’s and we’ve got a whole line of vapes and we’ve been actively looking to expand that product line. We have a full suite of products and services and want to be a premier medical marijuana company in Canada.” – Robert Abenante, CEO & President of Abattis Bioceuticals Corp.

Cultivating, licensing and more…

Abattis Bioceuticals Corp. is a specialty life sciences and biotechnology company. Through its operations and wholly owned subsidiaries, the Company has a broad range of capabilities including cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal marijuana markets in North America.

The XLABS mission is “to become the world’s best and Canada’s largest company dedicated to the Production, Management and Distribution of Premium cannabinoids-containing oils and isolates with API (Active Pharmaceutical Ingredient) grade purity, from in-situ Extraction and Purification to High Security Storage, as well as brokerage services including importation, sales and distribution of high purity oils and isolates across Canada and around the world.” or “to be a high margin Plants to Premium Products (“P2P”) innovator, through the creation of a scalable, cGMP-compliant, best practices, research backed global platform”.

For more information on Abattis Bioceuticals Corp.(ATT:CSE) please fill out the form below.

Request Investor Kit